Ignite Creation Date:
2024-07-17 @ 10:55 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06483815
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-05
First Post:
2024-06-29
Brief Title:
Fungal Infections During and After the SARS-CoV-2 Pandemic A Retrospective Comparison
Sponsor:
Bekir Sami Uyanık
Organization:
Hisar Intercontinental Hospital
Study Overview
Official Title:
Comparative Retrospective Analysis of Fungal Positivity Rates During and Post-SARS-CoV-2 Pandemic Periods
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
his study aims to retrospectively compare fungal positivity rates between the SARS-CoV-2 pandemic and the post-pandemic periods During the pandemic Candida species had a positivity rate of 1736 and Aspergillus had a rate of 222 Post-pandemic these rates decreased to 929 and 100 respectively The overall fungal positivity rate decreased from 915 during the pandemic to 513 post-pandemic Statistical analysis revealed a significant decrease in fungal positivity rates post-pandemic p 001 These findings underscore the effectiveness of post-pandemic healthcare interventions and infection control strategies
Detailed Description:
The study aims to retrospectively compare fungal positivity rates by focusing on Candida and Aspergillus species during the SARS-CoV-2 pandemic and in the post-pandemic period The dataset includes samples collected during the pandemic period N623 and the subsequent post-pandemic period N818 Fungal positivity rates were calculated and statistically analyzed using chi-square tests and significance was determined as p001
During the SARS-CoV-2 pandemic Candida species showed a positivity rate of 1736 while the rate in the post-pandemic period significantly decreased to 929 p0002 In contrast Aspergillus species did not show a significant change in positivity rates between the pandemic 222 and post-pandemic 100 periods p0186 NS
Overall the study provides valuable insights into the epidemiology of fungal infections during and after the SARS-CoV-2 pandemic suggesting possible shifts in fungal pathogen prevalence and healthcare priorities The findings contribute to the development of targeted healthcare strategies and surveillance measures for fungal infections in the post-pandemic era
Study Design Retrospective comparative analysis
Data Analysis Chi-square tests p001 considered significant
During the SARS-CoV-2 pandemic Candida species showed a positivity rate of 1736 while the rate in the post-pandemic period significantly decreased to 929 p0002 In contrast Aspergillus species did not show a significant change in positivity rates between the pandemic 222 and post-pandemic 100 periods p0186 NS
Overall the study provides valuable insights into the epidemiology of fungal infections during and after the SARS-CoV-2 pandemic suggesting possible shifts in fungal pathogen prevalence and healthcare priorities The findings contribute to the development of targeted healthcare strategies and surveillance measures for fungal infections in the post-pandemic era
Study Design Retrospective comparative analysis
Data Analysis Chi-square tests p001 considered significant
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None